Altus Pharmaceuticals , Nasdaq: ALTU.XX
Developing protein therapeutics for chronic gastrointestinal and metabolic disorders.
Industry: Health Care
First Day Return: +12.1%
Industry: Health Care
ALTU.XX
Developing protein therapeutics for chronic gastrointestinal and metabolic disorders.
| IPO Data | |
|---|---|
| IPO File Date | 10/17/2005 |
| Offer Price | $15.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 7.0 |
| Deal Size ($mm) | $105 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/25/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $105 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 1992 |
| Employees at IPO | n/a |
| Website www.altus.com | |
IPO News for Altus Pharmaceuticals
Altus Pharmaceuticals (ALTU.XX) Performance
